FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for TRAVATAN Z (travoprost) from Novartis Pharmaceuticals Corporation, resulting in updated labeling for the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TRAVATAN Z (TRAVOPROST)

Snippet

SUPPL AP for TRAVATAN Z (TRAVOPROST)